U.S. Allergy Diagnostics & Therapeutics Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug, & Other Allergens), By Test Type, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Allergen Type
                       1.2.3. Test Type
                       1.2.4. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Test outlook
                       2.2.2. Allergen Type outlook
                       2.2.3. Test Type outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Allergy Diagnostics & Therapeutics Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                       3.2.2. Market restraint analysis
                   3.3. U.S. Allergy Diagnostics & Therapeutics Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                   3.4. U.S. Allergy Diagnostics & Therapeutics Market: Pipeline Analysis
Chapter 4. U.S. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis
                   4.1. Type Segment Dashboard
                   4.2. U.S. Allergy Diagnostics & Therapeutics Market: Type Movement Analysis
                   4.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Type, 2018 To 2030 (USD Billion)
                   4.4. Diagnostics
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.4.2. Instruments
                           4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.4.3. Consumables
                           4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.4.4. Services
                           4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                   4.5. Therapeutics
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.2. Antihistamines
                           4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.3. Decongestants
                           4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.4. Corticosteroids
                           4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.5. Mast Cell Stabilizers
                           4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.6. Leukotriene Inhibitors
                           4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.7. Nasal Anti - Cholinergic
                           4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.8. Immuno - Modulators
                           4.5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.9. Epinephrine
                           4.5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       4.5.10. Immunotherapy
                           4.5.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis
                   5.1. Allergen Type Segment Dashboard
                   5.2. U.S. Allergy Diagnostics & Therapeutics Market: Allergen Type Movement Analysis
                   5.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, by Allergen Type, 2018 to 2030 (USD Billion)
                   5.4. Food
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.2. Dairy Products
                           5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.3. Poultry Product
                           5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.4. Tree Nuts
                           5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.5. Peanuts
                           5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.6. Shellfish
                           5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.7. Wheat
                           5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.8. Soys
                           5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       5.4.9. Other Food Allergens
                           5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                   5.5. Inhaled
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                   5.6. Drug
                       5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                   5.7. Other Allergens
                       5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Estimates & Trend Analysis
                   6.1. Test Type Segment Dashboard
                   6.2. U.S. Allergy Diagnostics & Therapeutics Market: Test Type Movement Analysis
                   6.3. U.S. Allergy Diagnostics & Therapeutics Market Size & Trend Analysis, By Test Type, 2018 to 2030 (USD Billion)
                   6.4. In vivo test
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       6.4.2. Skin Prick Test
                           6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       6.4.3. Intradermal Test
                           6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                       6.4.4. Patch Test
                           6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                   6.5. In vitro test
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Company/Competition Categorization
                   7.3. Vendor Landscape
                       7.3.1. Key company heat map analysis, 2024
                   7.4. Company Profiles
                       7.4.1. Thermo Fischer Scientific Inc.
                           7.4.1.1. Company overview
                           7.4.1.2. Financial performance
                           7.4.1.3. Type benchmarking
                           7.4.1.4. Strategic initiatives
                       7.4.2. Stallergenes Greer
                           7.4.2.1. Company overview
                           7.4.2.2. Financial performance
                           7.4.2.3. Type benchmarking
                           7.4.2.4. Strategic initiatives
                       7.4.3. HYCOR Biomedical
                           7.4.3.1. Company overview
                           7.4.3.2. Financial performance
                           7.4.3.3. Type benchmarking
                           7.4.3.4. Strategic initiatives
                       7.4.4. Minaris Medical America, Inc.
                           7.4.4.1. Company overview
                           7.4.4.2. Financial performance
                           7.4.4.3. Type benchmarking
                           7.4.4.4. Strategic initiatives
                       7.4.5. Omega Diagnostics Ltd
                           7.4.5.1. Company overview
                           7.4.5.2. Financial performance
                           7.4.5.3. Type benchmarking
                           7.4.5.4. Strategic initiatives
                       7.4.6. Lincoln Diagnostics, Inc.
                           7.4.6.1. Company overview
                           7.4.6.2. Financial performance
                           7.4.6.3. Type benchmarking
                           7.4.6.4. Strategic initiatives
                       7.4.7. Danaher Corporation
                           7.4.7.1. Company overview
                           7.4.7.2. Financial performance
                           7.4.7.3. Type benchmarking
                           7.4.7.4. Strategic initiatives
                       7.4.8. Alcon Inc.
                           7.4.8.1. Company overview
                           7.4.8.2. Financial performance
                           7.4.8.3. Type benchmarking
                           7.4.8.4. Strategic initiatives
                       7.4.9. AbbVie Inc.
                           7.4.9.1. Company overview
                           7.4.9.2. Financial performance
                           7.4.9.3. Type benchmarking
                           7.4.9.4. Strategic initiatives
                       7.4.10. Sanofi
                           7.4.10.1. Company overview
                           7.4.10.2. Financial performance
                           7.4.10.3. Type benchmarking
                           7.4.10.4. Strategic initiatives
                       7.4.11. Pfizer Inc.
                           7.4.11.1. Company overview
                           7.4.11.2. Financial performance
                           7.4.11.3. Type benchmarking
                           7.4.11.4. Strategic initiatives
                       7.4.12. Merck & Co., Inc.
                           7.4.12.1. Company overview
                           7.4.12.2. Financial performance
                           7.4.12.3. Type benchmarking
                           7.4.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. allergy diagnostics & therapeutics market, by type, 2018 - 2030 (USD Billion)
Table 3 U.S. allergy diagnostics & therapeutics market, by allergen type, 2018 - 2030 (USD Billion)
Table 4 U.S. allergy diagnostics & therapeutics market, by test type, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. Allergy Diagnostics & Therapeutics market: market outlook
Fig. 10 U.S. Allergy Diagnostics & Therapeutics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. Allergy Diagnostics & Therapeutics market driver impact
Fig. 16 U.S. Allergy Diagnostics & Therapeutics market restraint impact
Fig. 17 U.S. Allergy Diagnostics & Therapeutics market strategic initiatives analysis
Fig. 18 U.S. Allergy Diagnostics & Therapeutics market: type movement analysis
Fig. 19 U.S. Allergy Diagnostics & Therapeutics market: type outlook and key takeaways
Fig. 20 Diagnostics market estimates and forecast, 2018 - 2030
Fig. 21 Instrument market estimates and forecast, 2018 - 2030
Fig. 22 Consumable market estimates and forecast, 2018 - 2030
Fig. 23 Service market estimates and forecast, 2018 - 2030
Fig. 24 Therapeutics market estimates and forecast, 2018 - 2030
Fig. 25 Antihistamines market estimates and forecast, 2018 - 2030
Fig. 26 Decongestants market estimates and forecast, 2018 - 2030
Fig. 27 Corticosteroids market estimates and forecast, 2018 - 2030
Fig. 28 Mast cell stabilizers market estimates and forecast, 2018 - 2030
Fig. 29 Leukotriene inhibitors market estimates and forecast, 2018 - 2030
Fig. 30 Nasal anti – cholinergic market estimates and forecast, 2018 - 2030
Fig. 31 Immuno-modulators market estimates and forecast, 2018 - 2030
Fig. 32 Epinephrine market estimates and forecast, 2018 - 2030
Fig. 33 Immunotherapy market estimates and forecast, 2018 - 2030
Fig. 34 U.S. Allergy Diagnostics & Therapeutics market: allergen type movement analysis
Fig. 35 U.S. Allergy Diagnostics & Therapeutics market: allergen type outlook and key takeaways
Fig. 36 Food market estimates and forecasts, 2018 - 2030
Fig. 37 Dairy products market estimates and forecasts,2018 - 2030
Fig. 38 Poultry products market estimates and forecasts,2018- 2030
Fig. 39 Tree nuts market estimates and forecasts,2018 - 2030
Fig. 40 Peanuts market estimates and forecasts,2018 - 2030
Fig. 41 Shellfish market estimates and forecasts,2018 - 2030
Fig. 42 Soys market estimates and forecasts,2018 - 2030
Fig. 43 Other food allergens market estimates and forecasts,2018 - 2030
Fig. 44 Inhaled market estimates and forecasts,2018 - 2030
Fig. 45 Drug market estimates and forecasts,2018 - 2030
Fig. 46 Other allergens market estimates and forecasts,2018 - 2030
Fig. 47 U.S. Allergy Diagnostics & Therapeutics market: test type movement analysis
Fig. 48 U.S. Allergy Diagnostics & Therapeutics market: test type outlook and key takeaways
Fig. 49 North America market estimates and forecasts, 2018 - 2030
Fig. 50 In vivo test market estimates and forecasts, 2018 - 2030
Fig. 51 Skin prick test market estimates and forecasts, 2018 - 2030
Fig. 52 Intradermal market estimates and forecasts, 2018 - 2030
Fig. 53 Patch test market estimates and forecasts,2018 - 2030
Fig. 54 In vitro test market estimates and forecasts,2018 - 2030